Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging Stimulant and Non Stimulant Treatments for ADHD
NCT01678209Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Oct 2012
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate, atomoxetine in attention deficit hyperactivity disorder (ADHD), sponsored by Icahn School of Medicine at Mount Sinai. Started Oct 2012; status: completed.
02
Drugs
methylphenidateatomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01678209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01678209.